-
Something wrong with this record ?
Postdischarge nausea and vomiting (PDNV) in children: A review and observational study
M. Frelich, V. Vodicka, O. Jor, F. Bursa, M. Formanek, P. Sklienka, V. Prochazka
Language English Country Czech Republic
Document type Journal Article, Review
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
37222143
DOI
10.5507/bp.2023.020
Knihovny.cz E-resources
- MeSH
- Antiemetics * therapeutic use MeSH
- Child MeSH
- Humans MeSH
- Aftercare MeSH
- Postoperative Nausea and Vomiting prevention & control drug therapy MeSH
- Observational Studies as Topic MeSH
- Patient Discharge MeSH
- Prospective Studies MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Postdischarge nausea and vomiting (PDNV) cause substantial pediatric morbidity with potentially serious postoperative complications. However, few studies have addressed PDNV prevention and treatment in pediatric patients. Here we searched the literature and processed it in a narrative review describing PDNV incidence, risk factors, and management in pediatric patients.. A successful strategy for reducing PDNV considers both the pharmacokinetics of the antiemetic agents and the principle of multimodal prophylaxis, utilizing agents of different pharmacologic classes. Since many highly effective antiemetic agents have relatively short half-lives, a different approach must be used to prevent PDNV. A combination of oral and intravenous medications with longer half-lives, such as palonosetron or aprepitant, can be used. In addition, we designed a prospective observational study with the primary objective of determining PDNV incidence. In our study group of 205 children, the overall PDNV incidence was 14.6% (30 of 205), including 21 children suffering from nausea and 9 suffering from vomiting.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23008941
- 003
- CZ-PrNML
- 005
- 20230802075204.0
- 007
- ta
- 008
- 230707s2023 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2023.020 $2 doi
- 035 __
- $a (PubMed)37222143
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Frelich, Michal $u Department of Anesthesiology and Intensive Care Medicine, University Hospital of Ostrava, Czech Republic $u Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Czech Republic $7 xx0239894
- 245 10
- $a Postdischarge nausea and vomiting (PDNV) in children: A review and observational study / $c M. Frelich, V. Vodicka, O. Jor, F. Bursa, M. Formanek, P. Sklienka, V. Prochazka
- 520 9_
- $a Postdischarge nausea and vomiting (PDNV) cause substantial pediatric morbidity with potentially serious postoperative complications. However, few studies have addressed PDNV prevention and treatment in pediatric patients. Here we searched the literature and processed it in a narrative review describing PDNV incidence, risk factors, and management in pediatric patients.. A successful strategy for reducing PDNV considers both the pharmacokinetics of the antiemetic agents and the principle of multimodal prophylaxis, utilizing agents of different pharmacologic classes. Since many highly effective antiemetic agents have relatively short half-lives, a different approach must be used to prevent PDNV. A combination of oral and intravenous medications with longer half-lives, such as palonosetron or aprepitant, can be used. In addition, we designed a prospective observational study with the primary objective of determining PDNV incidence. In our study group of 205 children, the overall PDNV incidence was 14.6% (30 of 205), including 21 children suffering from nausea and 9 suffering from vomiting.
- 590 __
- $a
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a antiemetika $x terapeutické užití $7 D000932
- 650 _2
- $a pooperační nevolnost a zvracení $x prevence a kontrola $x farmakoterapie $7 D020250
- 650 _2
- $a následná péče $7 D000359
- 650 _2
- $a propuštění pacienta $7 D010351
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a pozorovací studie jako téma $7 D064887
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Vodička, Vojtěch $u Department of Anesthesiology and Intensive Care Medicine, University Hospital of Ostrava, Czech Republic $7 xx0271446
- 700 1_
- $a Jor, Ondřej, $u Department of Anesthesiology and Intensive Care Medicine, University Hospital of Ostrava, Czech Republic $u Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Czech Republic $d 1986- $7 xx0230461
- 700 1_
- $a Burša, Filip, $u Department of Anesthesiology and Intensive Care Medicine, University Hospital of Ostrava, Czech Republic $u Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Czech Republic $d 1982- $7 xx0199344
- 700 1_
- $a Formánek, Martin, $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital of Ostrava, Czech Republic $d 1987- $7 jo2015880806
- 700 1_
- $a Sklienka, Peter $u Department of Anesthesiology and Intensive Care Medicine, University Hospital of Ostrava, Czech Republic $u Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Czech Republic $7 xx0107715
- 700 1_
- $a Procházka, Václav, $u Radiodiagnostic Institute, University Hospital of Ostrava, Czech Republic $d 1961- $7 xx0070646
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 167, č. 2 (2023), s. 109-115
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37222143 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20230802075200 $b ABA008
- 999 __
- $a ok $b bmc $g 1964359 $s 1195204
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 167 $c 2 $d 109-115 $e 20230518 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK198 $a Pubmed-20230707